TNFRSF9 and lung cancer: We further confirmed that CD137 expression was higher in CD137+ Treg cells than in CD137+CD8+ T cells in the microenvironment, which clearly indicates the preferential binding of the CD137 mAb to CD137+ Treg cells, leading to functional Treg deletion by mAb-Fc, in lung cancer patients.